Chiffres calculés à partir des déclarations réglementaires officielles — .
Détentioninitiés 33.98% · institutions 32.38%
En EUR · au Oct 26, 2026
Interroger la machine
Recherchez et comparez les opérations d’initiés, les sociétés et leurs statistiques en langage courant. Votre question devient une requête sur les données disponibles, pas une conversation ni un conseil en investissement.
Données de MEDINCELL uniquement. Pas de recherche web. Les statistiques globales d’un initié sont exclues.
Une recherche exécutée consomme un crédit, même sans résultat. Les erreurs et les questions non prises en charge ne consomment rien.
MedinCell S.A. engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France. The company offers UZEDY, a subcutaneous risperidone for the treatment of schizophrenia. It also develops mdc-TJK, a subcutaneous injection, which is in NDA stage for the treatment of schizophrenia; and mdc-CWM, a sustained-release formulation of celecoxib, which is in Phase III clinical trial for the treatment and reduction of post-operative pain and inflammation. In addition, the company engages in the development of products in preclinical stage, including mdc-WWM for contraception; mdc-STM for the treatment of malaria; and mdc-AbbVie-1. It has strategic collaborations with TEVA, AIC, ABBVIE, Unitaid, and Gates Foundation. The company was incorporated in 2003 and is headquartered in Jacou, France.
Source des informations de marché · Oct 26, 2026
Chronologie sur le marché · historique complet
1 achat30 ventes— cours de clôturebarre = volume usd, échelle √cliquez sur une période pour filtrer le tableau
| Initié | Type | Valeur · USD | Signaux | Détail | |
|---|---|---|---|---|---|
| christophe douat | Vente | $2M | AMF | ||
| JULIE ALIMI | Achat | $42.1K | conv 60Premier en 12 mois | AMF | |
| STEPHANE POSTIC | Attribution | $51.2K | AMF | ||
| christophe douat | Vente | $660.7K | AMF | ||
| SABINE NGUYEN HORT | Vente | $98.2K | AMF | ||
| SABINE NGUYEN HORT | Vente | $27K | AMF | ||
| SABINE NGUYEN HORT | Vente | $16.4K | AMF | ||
| SABINE NGUYEN HORT | Vente | $91.2K | AMF | ||
| SABINE NGUYEN HORT | Vente | $29.7K | AMF | ||
| SABINE NGUYEN HORT | Vente | $60.8K | AMF | ||
| SABINE NGUYEN HORT | Vente | $41.2K | AMF | ||
| SABINE NGUYEN HORT | Vente | $184.3K | AMF | ||
| SABINE NGUYEN HORT | Vente | $30.5K | AMF | ||
| SABINE NGUYEN HORT | Vente | $56.5K | AMF | ||
| SABINE NGUYEN HORT | Vente | $74.6K | AMF | ||
| SABINE NGUYEN HORT | Vente | $68.5K | AMF | ||
| SABINE NGUYEN HORT | Vente | $54K | AMF | ||
| SABINE NGUYEN HORT | Vente | $26.5K | AMF | ||
| SABINE NGUYEN HORT | Vente | $7.1K | AMF | ||
| SABINE NGUYEN HORT | Vente | $6.8K | AMF | ||
| SABINE NGUYEN HORT | Vente | $66.9K | AMF | ||
| SABINE NGUYEN HORT | Vente | $148.1K | AMF | ||
| SABINE NGUYEN HORT | Vente | $60.7K | AMF | ||
| SABINE NGUYEN HORT | Vente | $21K | AMF | ||
| SABINE NGUYEN HORT | Vente | $37.7K | AMF |